Use and duration of chemotherapy and its impact.ppt

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Use and duration of chemotherapy and its impact

Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer 化疗的使用和周期对早期卵巢癌的生存期的影响 Helen E.Dinkelspiel,Ana I.Tergas,et al Department of Obstetrics and Gynecology,Columbia University College of Physicians and Surgeons,USA Gynecologic Oncology137(2015)203-209 Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer 化疗的使用和持续时间对早期卵巢癌的生存期的影响 Helen E.Dinkelspiel,Ana I.Tergas,et al Gynecologic Oncology137(2015)203-209 HIGHLIGHTS Among early-stage ovarian cancer patients practice patterns are widely divergent. 在早期卵巢癌病人的实际治疗中存在较大差异。 Extended duration chemotherapy does not appear to impact survival for women with high-risk disease. 长时间的化疗并没有明显改善高危患者的生存率。 ABSTRACT Objiective.Although 5-year survival for early-stage ovarian cancer is gnosis at recurrence is poor,necessitating appropriate initial management.We examined the patterns of care and the impact of the duration of chemotherapy on survival for women with early-stage ovarian cancer. 目的:虽然早期卵巢癌的5年生存率较高,但是如果复发,则预后极差,需要适当的初始管理.我们研究了治疗方式和化疗的持续时间对早期卵巢癌患者的生存期的影响. ABSTRACT Methods.We used the SEER-Medicare database to identify women ≧65 years of age with stage I ovarian cancer diagnosed from 1992 to 2009.Patients were categorized as low-risk(non-clear cell histology,stage IA or IB,grade 1 or 2)or high-risk (clear cell histology,grade 3,or stage IC).We used muitivariable logistic regression models to determine predictors of chemotherapy use and duration and COX proportional hazards models to evaluate the effect of chemotherapy use and duration on survival.  方法:我们用SEER-Medicare数据库,采选了从1992年到2009年,确诊为I期卵巢癌的≧65岁妇女。患者被分类为低危组(非透明细胞癌,分期是IA或IB,分级是1级或2级)和高危组(透明细胞癌,分级3级,或分期IC)。我们用多变量Logistic回归模型,以确定化疗药物的使用和持续时间的预测,以及Cox比例风险模型来评估化疗药物的使用和持续时间对生存的影响。 ABSTRACT Results.We identified 1394 patients.Among low-risk patients,32.9% received adjuvant chemotherapy and the use of chemotherapy increased with time.Among high-risk patients,71.9% received adjuvant chemotherapy;44.2%had≤3 months

文档评论(0)

糖糖 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档